Integrating Nonpharmacologic Strategies for Pain With Inclusion, Respect, and Equity
Launched by UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · Dec 13, 2023
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
The INSPIRE trial is studying new ways to manage chronic pain without relying on medications. This project aims to develop a mobile app and provide telehealth coaching to support Black, Chinese, and Latinx communities in the San Francisco Bay Area. The app will offer non-drug strategies for pain management, and the research will start with a small pilot program in November 2023, followed by a larger study in early 2025.
To participate in this trial, you need to be 18 years or older, speak English, Spanish, or Cantonese, and have a primary care provider at UCSF Health or SFHN. You'll also need to have chronic pain for at least three months and be willing to use a smartphone for the study. Participants will be involved in a 12-month program where they may be randomly assigned to different groups to compare the effectiveness of the approaches. It's important to note that individuals with severe mental illness that affects their ability to give informed consent cannot participate. Overall, this study hopes to provide valuable insights into effective pain management techniques for diverse communities.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. age 18 or older
- • 2. speak English, Spanish, or Cantonese
- • 3. have a UCSF Health or SFHN PCP
- • 4. be willing to use a smartphone (iOS or Android - either their own or one provided by the study)
- • 5. have chronic, non-malignant pain for at least 3 months
- • 6. be willing to participate in a 12 month patient-centered chronic pain management study where they will be randomized into one of two comparison arms
- Exclusion Criteria:
- • Severe mental illness or other condition preventing informed consent
About University Of California, San Francisco
The University of California, San Francisco (UCSF) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a focus on translating scientific discoveries into effective therapies, UCSF collaborates with a diverse array of stakeholders, including healthcare professionals, industry partners, and patient communities. The university's research programs emphasize interdisciplinary approaches and leverage cutting-edge technology to address complex medical challenges. As a sponsor of clinical trials, UCSF is dedicated to maintaining the highest standards of ethical conduct and scientific rigor, ensuring the safety and well-being of participants while contributing to the broader medical knowledge base.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Francisco, California, United States
San Francisco, California, United States
Patients applied
Trial Officials
Jason Satterfield, PhD
Principal Investigator
University of California, San Francisco
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported